Cited by 262Reproductive Health and TechnologiesOvarian function and disordersReproductive Biology and Fertility

A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

Open access
Imani, Babak, Eijkemans, Marinus J.C, te Velde, Egbert R, Habbema, J.Dik F, Fauser, Bart C.J.M·2002·Fertility and Sterility

Abstract

Objective To establish whether initial screening characteristics of normogonadotropic anovulatory infertile women can aid in predicting live birth after induction of ovulation with clomiphene citrate (CC).Design Prospective longitudinal single-center study.Setting Specialist academic fertility unit.Patient(s) Two hundred fifty-nine couples with a history of infertility, oligoamenorrhea, and normal follicle-stimulating hormone (FSH) concentrations who have not been previously treated with any ovulation-induction medication.Intervention(s) 50, 100, or 150 mg of oral CC per day, for 5 subsequent days per cycle.Main outcome measure(s) Conception leading to live birth after CC administration.Result(s) After receiving CC, 98 (38%) women conceived, leading to live birth. The cumulative live birth rate within 12 months was 42% for the total study population and 56% for the ovulatory women who had received CC. Factors predicting the chances for live birth included free androgen index (testosterone/sex hormone-binding globulin ratio), body mass index, cycle history (oligomenorrhea versus amenorrhea), and the woman's age.Conclusion(s) It is possible to predict the individual chances of live birth after CC administration using two distinct prediction models combined in a nomogram. Applying this nomogram in the clinic may be a step forward in optimizing the decision-making process in the treatment of normogonadotropic anovulatory infertility. Alternative first line of treatment options could be considered for some women who have limited chances for success.

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(01)02929-6

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The FAI, BMI, cycle history (oligomenorrhoea or amenorrhoea) and mean ovarian volume influence the ovarian response to stimulation with clomiphene citrate medication.

    “The FAI, but also BMI, cycle history (oligomenorrhoea or amenorrhoea) and mean ovarian volume, were found to be criteria that influence the ovarian response to stimulation with clomiphene citrate medication (Imani et al., 2002;Balen et al., 2016).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Imani, B., Eijkemans, M. J. C., te Velde, E. R., Habbema, J. D. F., & Fauser, B. C. J. M.
Affiliations
Erasmus MC (NL)
Corresponding author
Fauser, Bart C.J.M
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2002-01
Volume
77
Issue
1
Pages
91-97
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2081208329
Cited by
262
References
27
Citations by year
2026: 5 · 2025: 4 · 2024: 9 · 2023: 11 · 2022: 19 · 2021: 8 · 2020: 10 · 2019: 14 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 4 · 2013: 13 · 2012: 13
FWCI
11.75
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
clomiphene citrate, ovulation induction, oligoamenorrhea, live birth prediction, nomogram, free androgen index, body mass index, age, cumulative live birth rate, treatment decision-making
MeSH terms
Abortion, Spontaneous, Amenorrhea, Clomiphene, Ejaculation, Female, Fertility Agents, Female, Follicle Stimulating Hormone, Humans, Infant, Newborn, Infertility, Female, Insulin-Like Growth Factor I, Male, Oligomenorrhea, Ovulation, Ovulation Induction, Predictive Value of Tests, Pregnancy, Pregnancy Outcome, Probability, Retrospective Studies, Sperm Count, Odds Ratio, Treatment Outcome, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review